Portfolio (Quarterly)
Guide ↗
TANG CAPITAL MANAGEMENT LLC
· CIK 0001232621| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 300,000.0 | $8.0M | 0.40% | -1.2M | -80.0% | $26.71 | -19.9% |
| 22 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 349,220.0 | $7.5M | 0.37% | -251K | -41.8% | $21.52 | -13.2% |
| 23 | ARVN | ARVINAS INC | Healthcare | 569,698.0 | $6.8M | 0.33% | -824K | -59.1% | $11.86 | -23.4% |
| 24 | REGN | REGENERON PHARMACEUTICALS | Healthcare | 8,000.0 | $6.2M | 0.30% | -2K | -20.0% | $771.87 | -7.6% |
| 25 | — | KEZAR LIFE SCIENCES INC | — | 664,314.0 | $4.2M | 0.21% | -56K | -7.7% | $6.29 | — |
| 26 | CHRS | COHERUS ONCOLOGY INC | Healthcare | 2,724,509.0 | $3.9M | 0.19% | -2.4M | -46.5% | $1.42 | +10.6% |
| 27 | ERAS | ERASCA INC | Healthcare | 900,000.0 | $3.3M | 0.17% | -603K | -40.1% | $3.72 | +178.8% |
| 28 | NKTX | NKARTA INC | Healthcare | 1,480,823.0 | $2.7M | 0.14% | -5.6M | -79.0% | $1.85 | +51.9% |
| 29 | NUVL | NUVALENT INC | Healthcare | 21,880.0 | $2.2M | 0.11% | -28K | -56.2% | $100.59 | +3.8% |
| 30 | NMRA | NEUMORA THERAPEUTICS INC. | Healthcare | 967,235.0 | $1.7M | 0.09% | -433K | -30.9% | $1.79 | +10.1% |
| 31 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 15,640.0 | $1.2M | 0.06% | -84K | -84.4% | $79.65 | +87.7% |
| 32 | FATE | FATE THERAPEUTICS INC | Healthcare | 1,167,773.0 | $1.1M | 0.06% | -700K | -37.5% | $0.98 | +78.6% |
| 33 | — | ZYMEWORKS INC | — | 34,631.0 | $912K | 0.04% | -1.1M | -96.8% | $26.33 | — |
| 34 | RCKT | ROCKET PHARMACEUTICALS INC | Healthcare | 100,000.0 | $351K | 0.02% | -750K | -88.2% | $3.51 | -3.1% |
| 35 | TCRX | TSCAN THERAPEUTICS INC | Healthcare | 46,131.0 | $46K | 0.00% | -554K | -92.3% | $1.00 | +0.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
96.6%
Technology
1.3%
Financial Services
1.1%
Communication Services
0.9%
Real Estate
0.1%